Insider Transactions in Q2 2021 at Medifast Inc (MED)
Insider Transaction List (Q2 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 17
2021
|
Daniel R Chard Chairman & CEO |
SELL
Open market or private sale
|
Direct |
6,365
-0.53%
|
$1,680,360
$264.62 P/Share
|
Jun 16
2021
|
Daniel R Chard Chairman & CEO |
SELL
Open market or private sale
|
Direct |
5,824
-0.63%
|
$1,595,776
$274.7 P/Share
|
Jun 15
2021
|
Daniel R Chard Chairman & CEO |
SELL
Open market or private sale
|
Direct |
7,696
-0.69%
|
$2,147,184
$279.4 P/Share
|
Jun 14
2021
|
Daniel R Chard Chairman & CEO |
SELL
Open market or private sale
|
Direct |
7,079
-0.49%
|
$2,003,357
$283.97 P/Share
|
Jun 11
2021
|
Daniel R Chard Chairman & CEO |
SELL
Open market or private sale
|
Direct |
8,036
-0.97%
|
$2,330,440
$290.09 P/Share
|
Jun 03
2021
|
Jeffrey J Brown Director |
BUY
Grant, award, or other acquisition
|
Direct |
765
+21.86%
|
-
|
Jun 03
2021
|
Kevin G Byrnes Director |
BUY
Grant, award, or other acquisition
|
Direct |
650
+6.86%
|
-
|
Jun 03
2021
|
Constance J. Hallquist |
BUY
Grant, award, or other acquisition
|
Direct |
679
+8.86%
|
-
|
Jun 03
2021
|
Michael A. Hoer Director |
BUY
Grant, award, or other acquisition
|
Direct |
650
+14.67%
|
-
|
Jun 03
2021
|
Scott Schlackman Director |
BUY
Grant, award, or other acquisition
|
Direct |
669
+10.18%
|
-
|
Jun 03
2021
|
Andrea B Thomas Director |
BUY
Grant, award, or other acquisition
|
Direct |
659
+19.11%
|
-
|
May 19
2021
|
Scott Schlackman Director |
SELL
Open market or private sale
|
Direct |
1,000
-8.29%
|
$310,000
$310.83 P/Share
|
May 06
2021
|
Jeffrey J Brown Director |
BUY
Open market or private purchase
|
Indirect |
179
+0.62%
|
$40,275
$225.04 P/Share
|